EXHIBIT 99.1
Published on November 28, 2016
Exhibit 99.1
JOINT FILING AGREEMENT
Each of the undersigned hereby agrees that this Amendment No. 5 to Schedule 13D is being filed with the U.S. Securities and Exchange Commission on behalf of each of the undersigned pursuant to Rule 13d-1(k) under the U.S. Securities Exchange Act of 1934, as amended.
Date: November 28, 2016
| Mayne Pharma Ventures Pty Ltd | |
|
/s/ Mark Cansdale Mark Cansdale, Company Secretary
Mayne Pharma International Pty Ltd |
|
|
/s/ Mark Cansdale Mark Cansdale, Company Secretary
Mayne Pharma Group Limited |
|
|
/s/ Mark Cansdale Mark Cansdale, Company Secretary
|